Female Cancer Survivors Face Years of Neuropathy

Fall rate 24% higher in young women than in general population, elderly.

Almost half of female cancer survivors had persistent symptoms of chemotherapy-induced peripheral neuropathy (CIPN) for many years after treatment ended, experiencing functional decline and high risk of falls regardless of their age, researchers said.

Of 512 women cancer survivors enrolled in four clinical exercise intervention trials, 47% reported ongoing sensory loss in the lower extremities an average of 6 years after treatment stopped, according to Kerri M. Winters-Stone, PhD, of the Oregon Health & Science University in Portland, and colleagues.

Read Full Article Here >>